期刊文献+

大肠癌中CerbB-2、P53、PCNA蛋白的表达及临床意义 被引量:12

下载PDF
导出
摘要 目的:研究CerbB-2、P53、PCNA蛋白在大肠癌中的表达及其意义。方法:收集185例经手术切除、病理证实的大肠癌标本,应用免疫组化SP法检测该组大肠癌标本中CerbB-2、P53、PCNA蛋白的表达,所得结果运用SPSS10.0软件进行统计学分析。结果:CerbB-2和P53的阳性表达率分别为63.8%和59.5%,这两种蛋白的阳性表达均与组织分化程度、淋巴结转移、Dukes分期相关(P<0.05),与性别无相关性(P>0.05);而PCNA的强阳性表达率为77.8%,其表达与大肠癌组织分化程度相关(P<0.05),与性别、Dukes分期、淋巴结转移无关(P>0.05)。CerbB-2的表达与P53的表达有正相关性(r=0.248,P<0.05),PCNA的表达与P53的表达有正相关性(r=0.275,P<0.05),PCNA的表达与CerbB-2的表达无相关性(r=-0.05,P>0.05)。结论:CerbB-2、P53、PCNA的联合检测有助于大肠癌的诊断、恶性程度的判断和预后的估计,具有一定的临床价值。
出处 《实用医学杂志》 CAS 北大核心 2010年第16期2928-2930,共3页 The Journal of Practical Medicine
基金 上海市科委基金项目资助(编号:05DJ14010)
  • 相关文献

参考文献4

二级参考文献28

  • 1Yan Xin,Xiao Ling Li,Yan Ping Wang,Su Min Zhang,Hua Chuan Zheng,Dong Ying Wu,Yin Chang Zhang The Fourth Laboratory of Cancer Institute, China Medical University, Shenyang 110001, Liaoning Province, China.Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas[J].World Journal of Gastroenterology,2001,7(1):53-59. 被引量:39
  • 2Jun Hui Cui~1 Uwe Krueger~2 Doris Henne-Bruns~2 Bemd Kremer~2 Holger Kalthoff~2 ~1Department of General Surgery,First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,Zhejiang Province,China ~2Department of General Surgery,Christian-Albrechts-University,Kiel,GermanyDr.Jun Hui Cui graduated from Zhejiang Medical University in 1984,earned master degree in 1990,studied in the Surgical Department of Kiel University and worked in the Lab of Molecular Oncology of Kiel University from 1994-1997achieved M.D.from Kiel University.Germany,now associate professor of surgery,specialized in colorectal oncology.Adviser of graduated student for master degree,having 20 publications published in key Chinese or English journals..Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases[J].World Journal of Gastroenterology,2001,7(3):381-386. 被引量:19
  • 3Konishi F, Okada M, Nagai H, et al. Laparoscopic-assisted colectomy with lymph node dissection for invasive carcinoma of the colon [J]. Surg Today, 1996, 26( 11 ) : 882-889.
  • 4Mcleod H L, McKay J A, Collie-Duguid E S, et al. Therapeutic opportunities from tumor biology in metastatic colon cancer [J]. Eur J Cancer, 2000,36 ( 13 ) : 1706-1712.
  • 5Tono T, Ohzato H, Hasuike Y, et al. The efficacy and limitation of hepatic arterial infusion chemotherapy for colorectal cancer [J]. Gan To Kagaku Ryoho, 1999,26 ( 12 ) : 174 !- 1746.
  • 6Rodenhuis S, Slebos R J. Clinical significance of ras oncogene activation in human lung cancer [J-. Cancer Res, 1992, 52 (9): 2665-2669.
  • 7Jaeschke R, Guyatt G H, Sackett D L. Users' guides to the medical literature, III. How to use an article about a diagnostic test.B.What are the results and will they help me in caring for my patients .9 The Evidence-Based Medicine Working Group [J].JAMA, 1994,271(5) : 703-707.
  • 8任洪军,张全安,王奎,刘宝珠.大肠癌肝转移雌激素受体检测及其临床意义[J].实用临床医药杂志,2008,12(3):104-104. 被引量:2
  • 9郝立强,孟荣贵,张卫,戴建新.定量RT-PCR方法检测大肠癌外周血CEAmRNA方法及临床应用[J].大肠肛门病外科杂志,2001,17(1):8-10. 被引量:4
  • 10谭志军,胡先贵,应康,李瑶,唐榕,曹贵松,唐岩,金钢.胰腺癌伴淋巴结转移的基因芯片研究[J].中华肿瘤杂志,2002,24(3):243-246. 被引量:3

共引文献35

同被引文献116

引证文献12

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部